Quick Answer
Oscar Health, Inc. reported Diluted EPS of $1.69 per share (loss) for fiscal year 2025.
Oscar Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.69 | -1790.0% |
| 2024 | $0.10 | +108.2% |
| 2023 | -$1.22 | +57.2% |
| 2022 | -$2.85 | +10.9% |
| 2021 | -$3.20 | +77.4% |
| 2020 | -$14.16 | -56.3% |
| 2019 | -$9.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.53 | -140.9% | +40.4% |
| June 30, 2025 | -$0.89 | -545.0% | -196.7% |
| March 31, 2025 | $0.92 | +48.4% | +518.2% |
| September 30, 2024 | -$0.22 | +24.1% | -210.0% |
| June 30, 2024 | $0.20 | +385.7% | -67.7% |
| March 31, 2024 | $0.62 | +444.4% | +313.8% |
| September 30, 2023 | -$0.29 | +68.1% | -314.3% |
| June 30, 2023 | -$0.07 | +86.8% | +61.1% |
- Oscar Health, Inc. showed a decrease of -1790.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Oscar Health, Inc.’s diluted eps has grown by 81.3% (from $9.06 per share (loss) to $1.69 per share (loss)).
- The most recent figure is from Oscar Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: